Loading clinical trials...
Loading clinical trials...
To support advances in the understanding of pathophysiology and therapies of kidney diseases by creating a BioBank of kidney tissue, DNA, plasma, and urine from patients with kidney diseases.
A biorepository of human samples to support research to advance understanding of human kidney diseases will be created. Clinically, kidney diseases are detected by blood and urine laboratory tests. However, the underlying cause of kidney disease is often not clear on blood and urine tests. In such cases, a clinician may choose to perform a kidney biopsy to establish the diagnosis. Patients who are scheduled to undergo a kidney biopsy will be invited to participate in this proposed study.
Age
18 - 99 years
Sex
ALL
Healthy Volunteers
No
Yale New Haven Hospital, York Street Campus
New Haven, Connecticut, United States
Yale New Haven Hospital Saint Raphael Campus
New Haven, Connecticut, United States
Start Date
July 28, 2020
Primary Completion Date
August 1, 2030
Completion Date
August 1, 2035
Last Updated
August 13, 2025
1,000
ESTIMATED participants
Lead Sponsor
Yale University
Collaborators
NCT05806645
NCT07472426
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06656988